Home Newsfeeds Onconova Therapeutics Announces Rigosertib Data Presented At EADV As Late Breaker

Onconova Therapeutics Announces Rigosertib Data Presented At EADV As Late Breaker

Onconova Therapeutics, Inc. (NASDAQ:ONTX), ("Onconova", the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that a

byBenzinga Newsdesk

October 12, 2023

1 minute read

Onconova Therapeutics, Inc. (NASDAQ:Scientific Presentations section of the Onconova website following the Presentation.

Adobe’s Q4 Earnings Beat Cannot Offset Weak Q1, FY24 Total Revenue Forecast — Stock Sinks

By Ryan Gustafson

December 13, 6:52 PM

Adobe Inc. (NASDAQ: ADBE) shares are trading lower in Wednesday's after-hours session on the heels of the company's fourth-quarter earnings. Here's what you need to know.

ADBE

Citigroup Maintains Buy on MarketAxess Holdings, Raises Price Target to $415

By Benzinga Newsdesk

January 26, 12:03 PM

Citigroup analyst Christopher Allen maintains MarketAxess Holdings (NASDAQ:MKTX) with a Buy and raises the price target from $360 to $415.

MKTX

Centrus Energy Q4 EPS $1.42 Beats $0.82 Estimate, Sales $126.20M Beat $89.95M Estimate

By Benzinga Newsdesk

February 21, 6:13 PM

Centrus Energy (AMEX:LEU) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $0.82 by 73.17 percent. This is a 82.56 percent decrease over earnings of $8.14 per share from the

LEU

Cano Health Stock Plummets As CVS Health Abandons Buyout

By Vandana Singh

October 17, 1:28 PM

Cano Health Inc (NYSE: CANO) shares plunged after reports that CVS Health Corp (NYSE: CVS) has decided not to pursue an acquisition of Cano.

CANO

Onconova Therapeutics Announces Rigosertib Data Presented At EADV As Late Breaker

Related Posts

Adobe’s Q4 Earnings Beat Cannot Offset Weak Q1, FY24 Total Revenue Forecast — Stock Sinks

Citigroup Maintains Buy on MarketAxess Holdings, Raises Price Target to $415

Centrus Energy Q4 EPS $1.42 Beats $0.82 Estimate, Sales $126.20M Beat $89.95M Estimate

Cano Health Stock Plummets As CVS Health Abandons Buyout